New option listings for April 15th include Candel Therapeutics Inc (CADL), DESTINY TECH100 INC (DXYZ), and Sorrento Therapeutics Inc (SRNE).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CADL:
- Candel Therapeutics Gains Orphan Drug Status for Cancer Treatment
- Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
- Candel Therapeutics announces U.S. FDA granted ODD to CAN-2409
- Candel Therapeutics Unveils Breakthrough Immunotherapy Candidate
- Candel Therapeutics presents preclinical data on immunotherapy candidate
